The influence of provider characteristics on resection rates and survival in patients with localized non-small cell lung cancer
- PMID: 18164099
- DOI: 10.1016/j.lungcan.2007.10.029
The influence of provider characteristics on resection rates and survival in patients with localized non-small cell lung cancer
Abstract
Surgery remains the mainstay of treatment for localized non-small cell lung cancer (NSCLC). However, wide variations have been reported regarding rates of operative therapy. We examined the influence of characteristics of the hospital of diagnosis on the likelihood of receiving surgical treatment and on survival. We evaluated patients with primary, first-time, localized NSCLC diagnosed from 1998 to 2003 in the region of the Amsterdam Cancer Registry. Treatment and survival data were extracted from the registry database. We investigated which provider characteristics (hospital category, mean annual lung cancer caseload, presence of a cardiothoracic surgery unit) were predictive of receiving surgical treatment and of survival. 1591 patients were diagnosed with clinically localized NSCLC, of which 1097 (69%) had surgery. Resection rates varied significantly between the various hospitals (48-90%, chi(2), P<0.001). Patients diagnosed at specialized centers or higher volume hospitals were more likely to receive surgical therapy, especially for patients over 80 years of age. In addition, there was a trend that octogenarians had higher odds of undergoing surgery when diagnosed in a center with a cardiothoracic surgery unit. Patients had a better survival after resection than without surgery (P<0.001). Survival after surgery did not differ between the various hospital categories. In conclusion, there is wide institutional variability in rates of surgical treatment in lung cancer patients. In addition to patient characteristics, attributes of the hospital of diagnosis also have significant influence on the likelihood of receiving surgical therapy. Future studies should examine the underlying mechanisms for this phenomenon.
Similar articles
-
Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.Eur J Surg Oncol. 2010 Sep;36 Suppl 1:S83-92. doi: 10.1016/j.ejso.2010.06.020. Epub 2010 Jul 3. Eur J Surg Oncol. 2010. PMID: 20598845
-
Surgical treatment for non-small cell lung cancer in octogenarians--the usefulness of video-assisted thoracic surgery.Interact Cardiovasc Thorac Surg. 2009 Aug;9(2):274-7. doi: 10.1510/icvts.2008.199455. Epub 2009 May 7. Interact Cardiovasc Thorac Surg. 2009. PMID: 19423508
-
Effect of surgical volume and hospital type on outcome in non-small cell lung cancer surgery: a Finnish population-based study.Lung Cancer. 2008 Jan;59(1):119-25. doi: 10.1016/j.lungcan.2007.07.020. Epub 2007 Sep 10. Lung Cancer. 2008. PMID: 17825951
-
Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Arch Phys Med Rehabil. 2008. PMID: 18373987 Review.
-
Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?Interact Cardiovasc Thorac Surg. 2009 Mar;8(3):364-72. doi: 10.1510/icvts.2008.178947. Epub 2008 Jul 18. Interact Cardiovasc Thorac Surg. 2009. PMID: 18641014 Review.
Cited by
-
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia.Clin Transl Radiat Oncol. 2022 Mar 5;34:7-14. doi: 10.1016/j.ctro.2022.03.001. eCollection 2022 May. Clin Transl Radiat Oncol. 2022. PMID: 35282142 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical